Title: Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
Authors: Diener, Hans-Christoph
Eikelboom, John
Connolly, Stuart J
Joyner, Campbell D
Hart, Robert G
Lip, Gregory Y H
O'Donnell, Martin
Hohnloser, Stefan H
Hankey, Graeme J
Shestakovska, Olga
Yusuf, Salim
AVERROES Steering Committee and Investigators # ×
Issue Date: Mar-2012
Publisher: Lancet Pub. Group
Series Title: The Lancet Neurology vol:11 issue:3 pages:225-231
Abstract: In the AVERROES study, apixaban, a novel factor Xa inhibitor, reduced the risk of stroke or systemic embolism in patients with atrial fibrillation who were at high risk of stroke but unsuitable for vitamin K antagonist therapy. We aimed to investigate whether the subgroup of patients with previous stroke or transient ischaemic attack (TIA) would show a greater benefit from apixaban compared with aspirin than would patients without previous cerebrovascular events.
ISSN: 1474-4422
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science